Journal article
A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen
Indian journal of gastroenterology, v 13(1)
01 Jan 1994
PMID: 8119752
Abstract
BACKGROUNDThere have been conflicting data in literature about the value of Phyllanthus amarus in treating hepatitis B virus-related disorders. AIMTo evaluate the role of Phyllanthus amarus in eradication of the virus in hepatitis B carriers. METHODSPhyllanthus amarus was administered to 30 asymptomatic carriers of hepatitis B surface antigen (HBsAg) in a dosage of 250 to 500 mg thrice daily for 4 to 8 weeks. RESULTSNone of the 30 subjects cleared HBsAg. Phyllanthus amarus was well tolerated, with no clinical side effects or changes in the organ profiles for safety evaluation. CONCLUSIONPhyllanthus amarus is not effective in clearing HBsAg in asymptomatic carriers of the antigen.
Metrics
9 Record Views
Details
- Title
- A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen
- Creators
- J C DoshiA B VaidyaD S AntarkarR DeolalikarD H Antani
- Publication Details
- Indian journal of gastroenterology, v 13(1)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Microbiology and Immunology
- Scopus ID
- 2-s2.0-0028045930
- Other Identifier
- 991019222775904721